Biliary stent occlusion

##plugins.themes.academic_pro.article.main##

Dalila Gargouri
Asma Kochlef
Asma Ouekaa
Hela Elloumi
Afef Kilani
Malika Romani
Jamel Kharrat
Abdeljabbar Ghorbel

Abstract

Background : Endoscopic stent insertion is as a method of choice for palliative treatment of malignant biliary strictures. Two types of biliary stent were actually used plastic and metallic self-expandable. Occlusion of the stent can be observed in both.
Aim: To assess the management of biliary stent occlusion.
Methods : From january 2006 to december 2007, 120 biliary stents were inserted in 97 patients. Indications of biliary stents were malignant stricture in 67% of cases. Biliary stent occlusion was defined by necessity of stent replacement.
Results: 118 plastic and 2 metallic self-expandable biliary stents were inserted. Obstruction of the biliary stent was observed in 12 patients, after a mean time of 5,5 months [1-15]. A recurrent biliary desobstruction was necessary in 6 patients. Stent exchange was realised in 33,3% of cases for malignant biliary stenosis and in 66,6% for benign stricture (p=0,01). Obstruction of the stent was symptomatic (cholangitis, jaundice) in more of 50% of cases.
Management consisted on the stent exchange by a new plastic stent for clogging plastic stent and on insertion of plastic stent inside the metallic one for the occluded metallic stent.
Conclusion : Obstruction can occur for the two types of biliary stent. Survival of the patient, cost of the stent guide the choice of the stent will be used.

Keywords:

Biliary obstruction, , ERCP, biliary stent

##plugins.themes.academic_pro.article.details##

References

  1. Bauret P, Blanc P. Prothèses biliaires et obstructions malignes des voies biliaires extra-hépatiques. Gastroenterol Clin Biol 2000 ; 24 : 765-766
  2. Cipolletta L, Rotondano G, Marmo R, Bianco MA. Endoscopic palliation of malignant obstructive jaundice: an evidence-based review. Dig Liver Dis. 2007; 39 :375-88.
  3. D'alincourt A, Hamy A, Thibaud C, Redon H, Paineau J, Lerat F. Ictères obstructifs néoplasiques : apport des prothèses métalliques percutanées. Gastroenterol Clin Biol 2000 ; 24 :770-5.
  4. Stern N, Sturgess R. Endoscopic therapy in the management of malignant biliary obstruction. Eur J Surg Oncol. 2008;34 :313-7.
  5. Das A, Sivak MV Jr. Endoscopic palliation for inoperable pancreatic cancer. Cancer Control. 2000; 7 :452-7.
  6. Prat. F, De Baere T., Pelletier G. Traitement instrumental non chirurgical des pathologies biliaires intra- et extra-hépatiques. EMC - Hépatologie 2004 ; 1 : 15-34
  7. Letard JC, Sauterau D. Les prothèses biliaires. Hépato-gastro 1995 ; 2 : 413-9
  8. Shah SK , M. Mutigani, G. Costamagna. Therapeutic biliary endoscopy. Endoscopy 2002; 34: 43-53.
  9. Soehendra N, Reijnders-Frederic V. Palliative bile duct drainage. A new endoscopic method of introducing a transpapillary drain. Endoscopy 1980; 12:8-11.
  10. Carr-locke DL, Bull TJ, Counors PJ, Cotton PB, Geenen JE,Hawes RH et al. Mulicenterd, randomised trial of Wallstent biliary endoprothesis versus plastic stents. Gastrointest Endosc 1993; 39:310
  11. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340 : 1488-92.
  12. Groen AK, Out T, Huibregtse K, Delzenne B, Hoek FJ, Tytgat GNJ. Characterisation of the content of occluted biliary enoprostheses. Endoscopy 1987 ; 19 :57-9.
  13. Leung JW, Liu YL, Cheung SW et al. Effect of antibiotic-loaded hydrophilic stent in the prevention of bacterial adherence: a study of the charge, discharge and recharge concept using ciprofloxacin. Gastrointest Endosc 2001; 53:431-437
  14. Moesch C, Sautereau D, Cessot F, Berry P, Mounier M, Gainant A et al. Physicochemical and bacteriological analysis of the contents of occluded biliary endoprostheses. Hepatology 1991; 14:01142-6
  15. Barrioz T, Ingrand P, Besson I, labat J, Beauchant M. Ursodesoxycholic acid combined with norfloxacine prevented polyéthylène 1 - Faigel D.O. Preventing biliary stent occlusion. Gastrointest Endosc 2000; 51: 104-106.
  16. Browne S, Schmaltz M, Greene J. A comparison of biliary and pancreatic stent occlusion in antibiotic coated vs. conventional stents. Gastrointest Endos 1990;36: A 206.
  17. Faigel DO. Preventing biliary stent occlusion. Gastrointest Endosc. 2000 ;51 :104-7.
  18. Galandi D, Schwarzer G, Bassler D, Allgaier HP. Ursodeoxycholic acid and/or antibiotics for prevention of biliary stent occlusion. Cochrane Database Syst Rev. 2002; (3) : CD003043
  19. Halm U, Schiefke , Fleig WE, Mössner J, Keim V. Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial Endoscopy. 2001; 33:491-4.
  20. Leung JW, Libby ED, Morck DW et al. Is prophylactic ciprofloxacin effective in delaying biliary stent blochage. Gastrointest Endosc 2000; 52:175-182
  21. Huibregtse K, Carr-Locke DL, Cremer M, Domschke W, Fockens P et al. Biliary stent occlusion. A problem solved with self-expanding metal stents? European Wallstent Study Group. Endoscopy. 1992;24:391-4
  22. Kawamoto H, Ishida E, Okamoto Y, Okada H, Sakaguchi K et al. Evaluation of covered metallic stents in malignant biliary stenosisprominent effectiveness in gallbladder carcinoma. Hepatogastroenterology. 2005 ; 52:1351-6
  23. Bueno JT, Gerdes H, Kurtz RC.. Endoscopic management of occluded biliary Wallstents: a cancer center experience. Gastrointest Endosc. 2003; 58 :879-84.
  24. Gabelmann A, Hamid H, Brambs H.J, Rieber A. Metallic stents in benign biliary strictures: long-term effectiveness and interventional management of stent occlusion. Am J Roentgenol 2001; 177: 813-817.
  25. Togawa O, Kawabe T, Isayama H, Nakai Y, Sasaki T et al. Management of occluded uncovered metallic stents in patients with malignant distal biliary obstructions using covered metallic stents. J Clin Gastroenterol. 2008;42 :546-9.